cobalt chloride co-57

Small moleculeapproved

Approved

Dec 21, 1970

Cobaltous chloride CO-57 (or Cobalt 57) is a radioactive compound, decays by electron capture with a physical half-life of 270.9 days. This compound is a part of diagnostic capsules Rubratrope-57, for the diagnosis of pernicious anemia and as a diagnostic adjunct in other defects of intestinal vitamin B12 absorption. Rubratrope-57 was withdrawn in July 2017. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1970s

  1. Dec 21, 1970

    Bracco — Earliest FDA Approval

  2. Dec 21, 1970

    Bracco — NDA Secondary Org

  3. Dec 21, 1970

    Bracco — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedDec 21, 1970

Chemistry & pharmacology

Loading structure…

SMILES

[57Co++]
Mol. weight
56.936296235 g/mol
Chirality
Achiral Molecule
Inorganic
Yes
Polymer
No
Availability
Discontinued
Payload
57-cobalt

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 57co
  • 57co
  • cobalt chloride (57co)
  • cobalt chloride co-57
  • cobalt chloride co-57
  • cobaltous chloride (57co)
  • cobaltous chloride co 57
  • cobaltous chloride co 57
  • cobatope-57

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
BraccoFor profitNDA2Dec 21, 1970
BraccoFor profitNDADec 21, 1970